DR. KADE is a 130+ year-old independent pharmaceutical manufacturer based in Berlin, operating at 201–500 employees with domestic manufacturing and a Windows/SQL Server/GCP stack. Active hiring across manufacturing, engineering, and research signals continued production scaling; the project list reveals a company mid-way through digital transformation—moving from manual changeover and OEE optimization toward system integration, automated planning, and GMP compliance infrastructure. Pain points around setup times and production bottlenecks are driving cross-functional automation and lifecycle-management work.
DR. KADE manufactures pharmaceutical products focused on women's health and proctology, sold under a direct model emphasizing therapies for conditions often stigmatized or underserved. Founded in 1886 as a family-owned enterprise, the company operates manufacturing in-house in Germany and maintains tight quality standards across development, testing (including in-vitro release testing), and production. Current operations span product transfer, method development, and regulatory compliance (GMP). The company is actively hiring across manufacturing, engineering, and R&D roles in Germany, with steady velocity.
Windows Server, SQL Server, HPLC, GCP, Salesforce, Microsoft Office, Intune, Citrix, and Active Directory. The stack reflects pharma-grade analytical instrumentation (HPLC) integrated with enterprise Microsoft infrastructure.
Digital transformation of production, system integration, automated planning logic, GMP compliance, in-vitro release testing, and product/method transfers. Projects focus on reducing changeover times and improving operational efficiency.
Other companies in the same industry, closest in size